Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-12-12
2000-02-08
Kunz, Gary L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514451, 514460, 549273, A01N 4316, C07D30900
Patent
active
060228873
ABSTRACT:
Compounds of the formula ##STR1## wherein X in each of formulas (1) and (2) represents a substituted or unsubstituted alkylene, alkenylene, or alkynylene linker of 2-6C;
REFERENCES:
patent: 5258376 (1993-11-01), Bernstein
patent: 5280040 (1994-01-01), Labroo et al.
patent: 5545661 (1996-08-01), Cullinan
patent: 5604257 (1997-02-01), Tabe et al.
Mundy, G.R., "Regulation of Bone Formation by Bone Morphogenetic Proteins and Other Growth Factors," Clinical Orthopaedics and Related Research 323:24-28 (Mar. 1996).
Mundy, G.R., "Cytokines and Growth Factors in the Regulation of Bone Remodeling," Journal of Bone and Mineral Research 8(S2):S505-S510 (Dec. 1993).
Wozney, J.M., et al., "Novel Regulators of Bone Formation: Molecular Clones and Activities," Science (Dec. 16, 1988) 242:1528-1534.
Urist, M.R., "Bone: Formation by Autoinduction," Science (Nov. 12, 1965) 150:893-899.
Wozney, J.M., "The Bone Morphogenetic Protein Family and Osteogenesis," Molecular Reproduction and Development 32:160-167 (Jun. 1992).
Harris, S.E., et al., "Effects of Transforming Growth Factor .beta.on Bone Nodule Formation and Expression of Bone Morphogenetic Protein 2, Osteocalcin, Osteopontin, Alkaline Phosphatase, and Type I Collagen mRNA in Long-Term Cultures of Fetal Rat Calvarial Osteblasts," Journal of Bone Mineral Research 9(6):855-863 (Jun. 1994).
Stein, G.S., et al., "Bone cell differentiation: a functionally coupled relationship between expression of cell-growth-and tissue-specific genes," Current Opinion in Cell Biology 2:1018-1027 (Dec. 1990).
Wang, G-J., et al., "Lipid Clearing Agents in Steroid-induced Osteoporosis," J Formos Med Assoc 94(10):589-592 (Oct. 1995).
Cui, Q., et al., "Lovastatin Prevents Steroid-Induced Adipogenesis and Osteoporosis," Reports of the ASBMR 18.sup.th Annual Meeting (Sep. 1996) Journal of Bone and Mineral Research (Aug. 1996) 11 (Supplement 1):S510, p. S217.
Bellows, C.G., et al., "Determination of the Capacity for Proliferation and Differentiation of Osteoprogenitor Cells in the Presence and Absence of Dexamethasone,"Developmental Biology 140:132-138 (Jul. 1990).
Rickard, D.J., et al., "Induction of Rapid Osteoblast Differentiation in Rat Bone Marrow Stromal Cell Cultures by Dexamethasone and BMP-2," Developmental Biology 161:218-228 (Jan. 1994).
Ducy, P., et al., "Increased bone formation in osteocalcin-deficient mice," Nature (Aug. 1, 1996) 382:448-452.
Baindur Nand
Gasper Shirley R.
Labroo Virender M.
Martinez Theresa
McKernan Patricia A.
Kunz Gary L.
Moran Marjorie A.
Osteoscreen Inc.
ZymoGenetics Corporation
LandOfFree
Compositions and methods for stimulating bone growth does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for stimulating bone growth, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for stimulating bone growth will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1681730